Trial ID or NCT#

NCT02388295

Status

RECRUITING

Purpose

AZD3241 myeloperoxidase (MPO) inhibitor trial is assessing safety and tolerability, randomized trial, in patients with multiple system atrophy.

Investigator(s)

Kathleen Poston, MD, MS

Contact us to find out if this trial is right for you.

CONTACT

Maria Coburn